JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

Champions Oncology Inc

Chiusa

SettoreSettore sanitario

6.31 -0.47

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

6.11

Massimo

6.44

Metriche Chiave

By Trading Economics

Entrata

-6.3M

-1.8M

Vendite

-4.7M

12M

P/E

Media del settore

19.333

34.393

EPS

-0.07

Margine di Profitto

-14.852

Dipendenti

213

EBITDA

-6.9M

-2M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+88.09% upside

Dividendi

By Dow Jones

Utili prossimi

10 set 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-23M

88M

Apertura precedente

6.78

Chiusura precedente

6.31

Notizie sul Sentiment di mercato

By Acuity

34%

66%

95 / 374 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bearish Evidence

Champions Oncology Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

11 dic 2024, 23:55 UTC

Azioni calde

Stocks to Watch: Adobe, Champions Oncology, DBV Technologies

Confronto tra pari

Modifica del prezzo

Champions Oncology Inc Previsione

Obiettivo di Prezzo

By TipRanks

88.09% in crescita

Previsioni per 12 mesi

Media 12 USD  88.09%

Alto 12 USD

Basso 12 USD

Basato su 1 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Champions Oncology Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

1 ratings

1

Acquista

0

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

5.77 / 7.61Supporto e resistenza

A breve termine

Bearish Evidence

A termine intermedio

Very Strong Bearish Evidence

A lungo termine

Strong Bearish Evidence

Sentiment

By Acuity

95 / 374 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.